Complete financial analysis of CVS Health Corporation (CVS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of CVS Health Corporation, a leading company in the Medical – Healthcare Plans industry within the Healthcare sector.
You may be interested
- Nimtech Corp. (NMTT) Income Statement Analysis – Financial Results
- Rafael Holdings, Inc. (RFL) Income Statement Analysis – Financial Results
- Kaap Agri Limited (KAL.JO) Income Statement Analysis – Financial Results
- Qiniu Ltd (2567.HK) Income Statement Analysis – Financial Results
- Quantum-Si incorporated (QSI) Income Statement Analysis – Financial Results
CVS Health Corporation (CVS)
About CVS Health Corporation
CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. As of December 31, 2021, it operated approximately 9,900 retail locations and 1,200 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 357.78B | 322.47B | 292.11B | 268.71B | 256.78B | 194.58B | 184.79B | 177.55B | 153.29B | 139.37B | 126.76B | 123.12B | 107.08B | 95.78B | 98.22B | 87.47B | 76.33B | 43.82B | 37.01B | 30.59B | 26.59B | 24.18B | 22.24B | 20.09B | 18.10B | 15.27B | 13.75B | 11.83B | 9.76B | 11.29B | 10.44B | 10.43B | 9.89B | 8.69B | 7.55B | 6.78B | 5.93B | 5.26B | 4.77B |
| Cost of Revenue | 303.35B | 267.97B | 239.99B | 219.66B | 211.25B | 163.04B | 156.26B | 148.71B | 126.76B | 114.00B | 102.98B | 100.63B | 86.52B | 75.56B | 77.86B | 69.18B | 60.22B | 32.08B | 27.31B | 22.56B | 19.73B | 18.11B | 16.55B | 14.73B | 13.24B | 11.14B | 10.03B | 8.47B | 6.86B | 7.25B | 6.66B | 6.53B | 6.16B | 5.37B | 4.56B | 4.09B | 3.57B | 3.14B | 2.85B |
| Gross Profit | 54.43B | 54.50B | 52.12B | 49.05B | 45.53B | 31.54B | 28.53B | 28.83B | 26.53B | 25.37B | 23.78B | 22.49B | 20.56B | 20.22B | 20.36B | 18.29B | 16.11B | 11.74B | 9.69B | 8.03B | 6.86B | 6.07B | 5.69B | 5.36B | 4.86B | 4.13B | 3.72B | 3.36B | 2.90B | 4.03B | 3.77B | 3.90B | 3.72B | 3.31B | 2.99B | 2.69B | 2.36B | 2.12B | 1.92B |
| Gross Profit Ratio | 15.21% | 16.69% | 17.82% | 18.25% | 17.73% | 16.21% | 15.45% | 16.26% | 17.31% | 18.20% | 18.76% | 18.28% | 19.20% | 21.01% | 20.64% | 20.91% | 21.10% | 27.25% | 26.76% | 26.25% | 25.81% | 25.10% | 25.59% | 26.69% | 26.86% | 27.03% | 27.04% | 29.08% | 32.46% | 35.74% | 36.14% | 37.42% | 37.65% | 38.15% | 39.58% | 39.74% | 39.84% | 40.31% | 40.23% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 14.23B | 14.09B | 13.93B | 12.24B | 11.31B | 9.30B | 7.68B | 6.08B | 5.10B | 4.55B | 4.25B | 3.74B | 3.45B | 2.95B | 2.78B | 2.49B | 2.18B | 3.22B | 2.96B | 3.34B | 2.91B | 2.54B | 2.23B | 2.02B | 1.77B | 1.57B | 1.41B |
| Other Expenses | 40.69B | 46.55B | 38.81B | 35.14B | 33.54B | 27.52B | 18.99B | 18.45B | 17.05B | 16.57B | 15.75B | 15.28B | 0.00 | -10.00M | 0.00 | -200.00K | 0.00 | 0.00 | 0.00 | 496.80M | 341.70M | 310.30M | 673.30M | 296.60M | 277.90M | 249.70M | 242.60M | 262.80M | 327.70M | 206.30M | 191.60M | 201.00M | 138.50M | 114.40M | 97.80M | 82.20M | 72.00M | 64.10M | 63.10M |
| Operating Expenses | 40.69B | 46.55B | 38.81B | 35.14B | 33.54B | 27.52B | 18.99B | 18.45B | 17.05B | 16.57B | 15.75B | 15.28B | 14.23B | 14.08B | 13.93B | 12.24B | 11.31B | 9.30B | 7.68B | 6.58B | 5.44B | 4.86B | 4.92B | 4.04B | 3.73B | 3.20B | 3.02B | 2.75B | 2.51B | 3.42B | 3.15B | 3.54B | 3.05B | 2.65B | 2.33B | 2.11B | 1.84B | 1.64B | 1.47B |
| Cost & Expenses | 344.03B | 314.51B | 278.80B | 254.80B | 244.79B | 190.56B | 175.25B | 167.16B | 143.82B | 130.57B | 118.72B | 115.91B | 100.75B | 89.64B | 91.79B | 81.43B | 71.54B | 41.38B | 34.99B | 29.14B | 25.16B | 22.98B | 21.47B | 18.76B | 16.96B | 14.34B | 13.05B | 11.23B | 9.37B | 10.67B | 9.81B | 10.07B | 9.22B | 8.02B | 6.89B | 6.19B | 5.41B | 4.78B | 4.33B |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 21.00M | 20.00M | 21.00M | 15.00M | 8.00M | 4.00M | 4.00M | 3.00M | 5.00M | 21.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 2.66B | 2.29B | 2.50B | 2.91B | 3.04B | 2.62B | 1.06B | 1.08B | 859.00M | 615.00M | 517.00M | 561.00M | 588.00M | 539.00M | 530.00M | 530.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 4.37B | 4.22B | 4.49B | 4.44B | 4.37B | 2.72B | 2.48B | 2.48B | 2.09B | 1.93B | 1.87B | 1.75B | 1.57B | 1.47B | 1.39B | 1.27B | 1.09B | 733.30M | 589.10M | 439.90M | 341.70M | 310.30M | 320.80M | 296.60M | 277.90M | 249.70M | 242.60M | 262.80M | 327.70M | 206.30M | 191.60M | 201.00M | 138.50M | 114.40M | 97.80M | 82.20M | 72.00M | 64.10M | 63.10M |
| EBITDA | 18.20B | 12.35B | 17.53B | 17.12B | 16.40B | 6.74B | 11.81B | 12.19B | 11.57B | 10.22B | 9.92B | 8.62B | 7.90B | 7.61B | 7.82B | 7.34B | 5.89B | 3.17B | 2.61B | 1.95B | 1.77B | 1.52B | 1.44B | 1.62B | 1.41B | 1.18B | 946.70M | 867.50M | 723.90M | 817.00M | 814.90M | 561.90M | 808.10M | 778.60M | 758.70M | 671.80M | 595.60M | 547.60M | 512.10M |
| EBITDA Ratio | 5.08% | 6.21% | 6.74% | 6.91% | 6.42% | 6.63% | 6.49% | 7.58% | 7.53% | 7.71% | 7.82% | 7.58% | 7.37% | 7.92% | 7.93% | 8.37% | 7.71% | 7.25% | 7.05% | 6.38% | 2.57% | 6.27% | 8.08% | 8.06% | 7.81% | 8.76% | 10.30% | 5.54% | 14.02% | 7.23% | 7.79% | 5.37% | 8.17% | 9.07% | 10.15% | 9.98% | 10.11% | 10.47% | 10.74% |
| Operating Income | 13.74B | 7.95B | 13.31B | 13.91B | 11.99B | 4.02B | 9.54B | 10.39B | 9.48B | 8.80B | 8.04B | 7.21B | 6.33B | 6.14B | 6.43B | 6.05B | 4.79B | 2.44B | 2.02B | 1.45B | 1.42B | 1.21B | 770.60M | 1.32B | 1.14B | 930.50M | 704.10M | 604.70M | 396.20M | 610.70M | 623.30M | 360.90M | 669.60M | 664.20M | 660.90M | 589.60M | 523.60M | 483.50M | 449.00M |
| Operating Income Ratio | 3.84% | 4.89% | 4.52% | 5.18% | 4.67% | 2.07% | 5.15% | 5.82% | 6.17% | 6.31% | 6.34% | 5.87% | 5.91% | 6.39% | 6.52% | 6.91% | 6.28% | 5.57% | 5.46% | 4.75% | 1.29% | 4.99% | 3.46% | 6.58% | 6.27% | 6.09% | 5.04% | 5.42% | 2.00% | 5.41% | 5.97% | 3.46% | 6.77% | 7.65% | 8.75% | 8.70% | 8.83% | 9.19% | 9.40% |
| Total Other Income/Expenses | -2.57B | -2.12B | -2.77B | -4.14B | -2.99B | -2.62B | -1.27B | -1.75B | -859.00M | -1.12B | -509.00M | -905.00M | -584.00M | -536.00M | -525.00M | -509.00M | -434.60M | -215.80M | -110.50M | -58.30M | -48.10M | -50.40M | -61.00M | -79.30M | -59.10M | -239.50M | -466.50M | 38.70M | -280.00M | -84.50M | -71.10M | -79.20M | -80.00M | -76.90M | -54.80M | -47.10M | -47.50M | -51.30M | -57.80M |
| Income Before Tax | 11.17B | 5.84B | 10.54B | 9.77B | 9.00B | 1.41B | 8.27B | 8.64B | 8.62B | 7.68B | 7.53B | 6.31B | 5.75B | 5.60B | 5.90B | 5.54B | 4.36B | 2.23B | 1.91B | 1.40B | 1.38B | 1.16B | 709.60M | 1.24B | 1.08B | 691.00M | 237.60M | 643.40M | 116.20M | 526.20M | 552.20M | 281.70M | 589.60M | 587.30M | 606.10M | 542.50M | 476.10M | 432.20M | 391.20M |
| Income Before Tax Ratio | 3.12% | 1.81% | 3.57% | 3.64% | 3.50% | 0.72% | 4.47% | 4.87% | 5.62% | 5.51% | 5.94% | 5.14% | 5.37% | 5.84% | 5.99% | 6.33% | 5.71% | 5.08% | 5.16% | 4.56% | 5.17% | 4.78% | 3.19% | 6.19% | 5.95% | 4.66% | 1.22% | 7.30% | -8.23% | 4.66% | 5.29% | 2.70% | 5.96% | 6.76% | 8.02% | 8.00% | 8.03% | 8.21% | 8.19% |
| Income Tax Expense | 2.81B | 1.51B | 2.55B | 2.57B | 2.37B | 2.00B | 1.64B | 3.32B | 3.39B | 3.03B | 2.93B | 2.44B | 2.26B | 2.18B | 2.20B | 2.19B | 1.72B | 856.90M | 684.30M | 477.60M | 528.20M | 439.20M | 296.40M | 497.40M | 441.30M | 306.50M | 149.20M | 271.00M | 58.40M | 218.70M | 220.40M | 125.70M | 242.90M | 202.00M | 208.00M | 188.00M | 190.70M | 193.90M | 171.40M |
| Net Income | 8.34B | 4.31B | 8.00B | 7.18B | 6.63B | -594.00M | 6.62B | 5.32B | 5.24B | 4.64B | 4.59B | 3.86B | 3.46B | 3.43B | 3.70B | 3.21B | 2.64B | 1.37B | 1.22B | 918.80M | 847.30M | 716.60M | 413.20M | 746.00M | 635.10M | 384.50M | 88.80M | 208.20M | -572.80M | 307.50M | 331.80M | 133.40M | 346.70M | 385.30M | 398.10M | 354.50M | 285.40M | 238.30M | 210.20M |
| Net Income Ratio | 2.33% | 1.34% | 2.74% | 2.67% | 2.58% | -0.31% | 3.58% | 3.00% | 3.42% | 3.33% | 3.62% | 3.15% | 3.23% | 3.55% | 3.74% | 3.67% | 3.45% | 3.12% | 3.31% | 3.00% | 3.19% | 2.96% | 1.86% | 3.71% | 3.51% | 2.60% | 0.30% | 1.36% | -6.78% | 2.72% | 3.18% | 1.28% | 3.51% | 4.44% | 5.27% | 5.23% | 4.81% | 4.53% | 4.40% |
| EPS | 6.49 | 3.29 | 6.00 | 5.48 | 5.10 | -0.57 | 6.47 | 4.93 | 4.66 | 3.98 | 3.77 | 3.05 | 2.59 | 2.51 | 2.58 | 2.23 | 1.97 | 1.65 | 1.49 | 1.13 | 1.06 | 0.90 | 0.51 | 0.94 | 0.80 | 0.48 | 0.10 | 0.27 | -1.52 | 0.69 | 0.60 | 0.28 | 0.80 | 0.90 | 0.89 | 0.41 | 0.66 | 0.55 | 0.49 |
| EPS Diluted | 6.47 | 3.26 | 5.95 | 5.46 | 5.08 | -0.57 | 6.44 | 4.90 | 4.63 | 3.96 | 3.74 | 3.03 | 2.57 | 2.49 | 2.55 | 2.18 | 1.92 | 1.60 | 1.45 | 1.10 | 1.03 | 0.88 | 0.50 | 0.92 | 0.78 | 0.48 | 0.10 | 0.26 | -1.52 | 0.69 | 0.60 | 0.28 | 0.80 | 0.90 | 0.89 | 0.41 | 0.66 | 0.55 | 0.49 |
| Weighted Avg Shares Out | 1.29B | 1.31B | 1.32B | 1.31B | 1.30B | 1.04B | 1.02B | 1.07B | 1.12B | 1.16B | 1.22B | 1.27B | 1.34B | 1.37B | 1.43B | 1.43B | 1.33B | 820.60M | 811.40M | 800.53M | 785.57M | 784.60M | 781.37M | 782.25M | 782.60M | 774.20M | 751.00M | 426.40M | 432.00M | 422.55M | 525.00M | 420.36M | 413.63M | 410.44M | 430.67M | 435.81M | 432.27M | 433.09M | 433.20M |
| Weighted Avg Shares Out (Dil) | 1.29B | 1.32B | 1.33B | 1.31B | 1.31B | 1.04B | 1.02B | 1.08B | 1.13B | 1.17B | 1.23B | 1.28B | 1.35B | 1.38B | 1.45B | 1.47B | 1.37B | 853.20M | 841.60M | 822.36M | 808.45M | 810.60M | 797.00M | 799.34M | 817.80M | 810.40M | 790.53M | 426.40M | 432.00M | 422.55M | 529.41M | 420.36M | 413.63M | 410.44M | 430.67M | 435.81M | 432.27M | 433.09M | 433.20M |
Curious about CVS Health (CVS) Q3 Performance? Explore Wall Street Estimates for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for CVS Health (CVS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2024.
Earnings Preview: CVS Health (CVS) Q3 Earnings Expected to Decline
CVS Health (CVS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CVS ALERT: Bragar Eagel & Squire, P.C. is Investigating CVS Health Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against CVS Health Corporation (NYSE: CVS) on behalf of long-term stockholders following a class action complaint...
CVS Health (CVS) Stock Sinks As Market Gains: Here's Why
CVS Health (CVS) closed at $56.25 in the latest trading session, marking a -1.94% move from the prior day.
CVS Q3 Estimates Plunge Before Earnings Release: How to Play the Stock
CVS Health faces outpatient and supplemental benefits pressure within Health Care Benefits.
CVS Health Stock Dip: Undervalued And Ready For A Turnaround
CVS Health dropped ~10% following Q3 earnings, impacted by a $1.1B Medicare charge and a $1.2B restructuring charge. CVS's FY2024 EPS forecast is $6.47, down 26.01% YoY, reflecting financial challenges, but FY2025 recovery is projected at $7.30, up 13%. The...
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
CVS Health Foundation helps address barriers to care for patients with chronic diseases in Atlanta
Foundation announces $1.5 million in new Health Zones funding and progress through first six months of the program WOONSOCKET, R.I. , Oct. 23, 2024 /PRNewswire/ -- The CVS Health® Foundation today announced $1.5 million in new Health Zones funding between Good...
Walmart will start delivering prescriptions to customers' doorsteps as CVS and Walgreens struggle
Walmart said Tuesday that it will start delivering prescriptions to customers' doorsteps. The discounter will start with six states, but plans to offer prescription delivery in 49 states by the end of January.
CVS's Karen Lynch was just ousted. Why women CEOs are 45% more likely to get fired than men.
At the present rate, it will take 81 years to achieve gender parity among the CEO class
Source: https://incomestatements.info
Category: Stock Reports